The Microbiome is a Welcome Addition to the Growing "Omes" of Cardiopulmonary Bypass in Congenital Heart Disease Surgery

Affiliations

Editorial

John D Watson et al. JACC Basic Transl Sci. 2021.

. 2021 Apr 27;6(4):328-330.

doi: 10.1016/j.jacbts.2021.02.003. eCollection 2021 Apr.

No abstract available

Keywords: cardiopulmonary bypass; congenital heart disease; microbiome; pediatric.

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass.
Salomon J, Ericsson A, Price A, Manithody C, Murry DJ, Chhonker YS, Buchanan P, Lindsey ML, Singh AB, Jain AK. Salomon J, et al. JACC Basic Transl Sci. 2021 Mar 3;6(4):311-327. doi: 10.1016/j.jacbts.2020.12.012. eCollection 2021 Apr. JACC Basic Transl Sci. 2021. PMID: 33997519 Free PMC article.

1. Davidson J.A., Pfeifer Z., Frank B. Metabolomic fingerprinting of infants undergoing cardiopulmonary bypass: changes in metabolic pathways and association with mortality and cardiac intensive care unit length of stay. J Am Heart Assoc. 2018;7 - PMC - PubMed
1. Frank B.S., Khailova L., Silveira L. Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls. Transl Res. 2021;229:24–37. - PMC - PubMed
1. Salomon J., Ericsson A., Price A. Dysbiosis and intestinal barrier dysfunction in pediatric congenital heart disease is exacerbated following cardiopulmonary bypass. J Am Coll Cardiol Basic Trans Science. 2021;6:311–327. - PMC - PubMed
1. Witkowski M., Weeks T.L., Hazen S.L. Gut microbiota and cardiovascular disease. Circ Res. 2020;127:553–570. - PMC - PubMed
1. Denning N.L., Prince J.M. Neonatal intestinal dysbiosis in necrotizing enterocolitis. Mol Med. 2018;24:4. - PMC - PubMed